BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1424 related articles for article (PubMed ID: 29875239)

  • 1.
    Martins MA; Tully DC; Pedreño-Lopez N; von Bredow B; Pauthner MG; Shin YC; Yuan M; Lima NS; Bean DJ; Gonzalez-Nieto L; Domingues A; Gutman MJ; Maxwell HS; Magnani DM; Ricciardi MJ; Bailey VK; Altman JD; Burton DR; Ejima K; Allison DB; Evans DT; Rakasz EG; Parks CL; Bonaldo MC; Capuano S; Lifson JD; Desrosiers RC; Allen TM; Watkins DI
    J Virol; 2018 Aug; 92(16):. PubMed ID: 29875239
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Frequency of Vaccine-Induced T-Cell Responses Does Not Predict the Rate of Acquisition after Repeated Intrarectal SIVmac239 Challenges in
    Martins MA; Gonzalez-Nieto L; Shin YC; Domingues A; Gutman MJ; Maxwell HS; Magnani DM; Ricciardi MJ; Pedreño-Lopez N; Bailey VK; Altman JD; Parks CL; Allison DB; Ejima K; Rakasz EG; Capuano S; Desrosiers RC; Lifson JD; Watkins DI
    J Virol; 2019 Mar; 93(5):. PubMed ID: 30541854
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vaccine-Induced Simian Immunodeficiency Virus-Specific CD8+ T-Cell Responses Focused on a Single Nef Epitope Select for Escape Variants Shortly after Infection.
    Martins MA; Tully DC; Cruz MA; Power KA; Veloso de Santana MG; Bean DJ; Ogilvie CB; Gadgil R; Lima NS; Magnani DM; Ejima K; Allison DB; Piatak M; Altman JD; Parks CL; Rakasz EG; Capuano S; Galler R; Bonaldo MC; Lifson JD; Allen TM; Watkins DI
    J Virol; 2015 Nov; 89(21):10802-20. PubMed ID: 26292326
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vectored Gag and Env but not Tat show efficacy against simian-human immunodeficiency virus 89.6P challenge in Mamu-A*01-negative rhesus monkeys.
    Liang X; Casimiro DR; Schleif WA; Wang F; Davies ME; Zhang ZQ; Fu TM; Finnefrock AC; Handt L; Citron MP; Heidecker G; Tang A; Chen M; Wilson KA; Gabryelski L; McElhaugh M; Carella A; Moyer C; Huang L; Vitelli S; Patel D; Lin J; Emini EA; Shiver JW
    J Virol; 2005 Oct; 79(19):12321-31. PubMed ID: 16160159
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patterns of CD8+ immunodominance may influence the ability of Mamu-B*08-positive macaques to naturally control simian immunodeficiency virus SIVmac239 replication.
    Loffredo JT; Bean AT; Beal DR; León EJ; May GE; Piaskowski SM; Furlott JR; Reed J; Musani SK; Rakasz EG; Friedrich TC; Wilson NA; Allison DB; Watkins DI
    J Virol; 2008 Feb; 82(4):1723-38. PubMed ID: 18057253
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ALVAC-SIV-gag-pol-env-based vaccination and macaque major histocompatibility complex class I (A*01) delay simian immunodeficiency virus SIVmac-induced immunodeficiency.
    Pal R; Venzon D; Letvin NL; Santra S; Montefiori DC; Miller NR; Tryniszewska E; Lewis MG; VanCott TC; Hirsch V; Woodward R; Gibson A; Grace M; Dobratz E; Markham PD; Hel Z; Nacsa J; Klein M; Tartaglia J; Franchini G
    J Virol; 2002 Jan; 76(1):292-302. PubMed ID: 11739694
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Escape from CD8(+) T cell responses in Mamu-B*00801(+) macaques differentiates progressors from elite controllers.
    Mudd PA; Ericsen AJ; Burwitz BJ; Wilson NA; O'Connor DH; Hughes AL; Watkins DI
    J Immunol; 2012 Apr; 188(7):3364-70. PubMed ID: 22387557
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vaccination with Gag, Vif, and Nef gene fragments affords partial control of viral replication after mucosal challenge with SIVmac239.
    Martins MA; Wilson NA; Piaskowski SM; Weisgrau KL; Furlott JR; Bonaldo MC; Veloso de Santana MG; Rudersdorf RA; Rakasz EG; Keating KD; Chiuchiolo MJ; Piatak M; Allison DB; Parks CL; Galler R; Lifson JD; Watkins DI
    J Virol; 2014 Jul; 88(13):7493-516. PubMed ID: 24741098
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vaccine-induced immune responses against both Gag and Env improve control of simian immunodeficiency virus replication in rectally challenged rhesus macaques.
    Martins MA; Shin YC; Gonzalez-Nieto L; Domingues A; Gutman MJ; Maxwell HS; Castro I; Magnani DM; Ricciardi M; Pedreño-Lopez N; Bailey V; Betancourt D; Altman JD; Pauthner M; Burton DR; von Bredow B; Evans DT; Yuan M; Parks CL; Ejima K; Allison DB; Rakasz E; Barber GN; Capuano S; Lifson JD; Desrosiers RC; Watkins DI
    PLoS Pathog; 2017 Jul; 13(7):e1006529. PubMed ID: 28732035
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rectal Acquisition of Simian Immunodeficiency Virus (SIV) SIVmac239 Infection despite Vaccine-Induced Immune Responses against the Entire SIV Proteome.
    Martins MA; Gonzalez-Nieto L; Ricciardi MJ; Bailey VK; Dang CM; Bischof GF; Pedreño-Lopez N; Pauthner MG; Burton DR; Parks CL; Earl P; Moss B; Rakasz EG; Lifson JD; Desrosiers RC; Watkins DI
    J Virol; 2020 Nov; 94(24):. PubMed ID: 33028714
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytotoxic T-lymphocyte escape does not always explain the transient control of simian immunodeficiency virus SIVmac239 viremia in adenovirus-boosted and DNA-primed Mamu-A*01-positive rhesus macaques.
    McDermott AB; O'Connor DH; Fuenger S; Piaskowski S; Martin S; Loffredo J; Reynolds M; Reed J; Furlott J; Jacoby T; Riek C; Dodds E; Krebs K; Davies ME; Schleif WA; Casimiro DR; Shiver JW; Watkins DI
    J Virol; 2005 Dec; 79(24):15556-66. PubMed ID: 16306626
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vaccine protection against simian immunodeficiency virus in monkeys using recombinant gamma-2 herpesvirus.
    Bilello JP; Manrique JM; Shin YC; Lauer W; Li W; Lifson JD; Mansfield KG; Johnson RP; Desrosiers RC
    J Virol; 2011 Dec; 85(23):12708-20. PubMed ID: 21900170
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combination Adenovirus and Protein Vaccines Prevent Infection or Reduce Viral Burden after Heterologous Clade C Simian-Human Immunodeficiency Virus Mucosal Challenge.
    Malherbe DC; Mendy J; Vang L; Barnette PT; Reed J; Lakhashe SK; Owuor J; Gach JS; Legasse AW; Axthelm MK; LaBranche CC; Montefiori D; Forthal DN; Park B; Wilson JM; McLinden JH; Xiang J; Stapleton JT; Sacha JB; Haynes BF; Liao HX; Ruprecht RM; Smith J; Gurwith M; Haigwood NL; Alexander J
    J Virol; 2018 Jan; 92(2):. PubMed ID: 29093095
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of Complement-Mediated Lysis of Simian Immunodeficiency Virus (SIV) and SIV-Infected Cells Reveals Sex Differences in Vaccine-Induced Immune Responses in Rhesus Macaques.
    Miller-Novak LK; Das J; Musich TA; Demberg T; Weiner JA; Venzon DJ; Mohanram V; Vargas-Inchaustegui DA; Tuero I; Ackerman ME; Alter G; Robert-Guroff M
    J Virol; 2018 Oct; 92(19):. PubMed ID: 30021899
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Non-neutralizing Antibodies May Contribute to Suppression of SIVmac239 Viremia in Indian Rhesus Macaques.
    Pedreño-Lopez N; Rosen BC; Flores WJ; Gorman MJ; Voigt TB; Ricciardi MJ; Crosno K; Weisgrau KL; Parks CL; Lifson JD; Alter G; Rakasz EG; Magnani DM; Martins MA; Watkins DI
    Front Immunol; 2021; 12():657424. PubMed ID: 33796119
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Infection with "escaped" virus variants impairs control of simian immunodeficiency virus SIVmac239 replication in Mamu-B*08-positive macaques.
    Valentine LE; Loffredo JT; Bean AT; León EJ; MacNair CE; Beal DR; Piaskowski SM; Klimentidis YC; Lank SM; Wiseman RW; Weinfurter JT; May GE; Rakasz EG; Wilson NA; Friedrich TC; O'Connor DH; Allison DB; Watkins DI
    J Virol; 2009 Nov; 83(22):11514-27. PubMed ID: 19726517
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low-dose penile SIVmac251 exposure of rhesus macaques infected with adenovirus type 5 (Ad5) and then immunized with a replication-defective Ad5-based SIV gag/pol/nef vaccine recapitulates the results of the phase IIb step trial of a similar HIV-1 vaccine.
    Qureshi H; Ma ZM; Huang Y; Hodge G; Thomas MA; DiPasquale J; DeSilva V; Fritts L; Bett AJ; Casimiro DR; Shiver JW; Robert-Guroff M; Robertson MN; McChesney MB; Gilbert PB; Miller CJ
    J Virol; 2012 Feb; 86(4):2239-50. PubMed ID: 22156519
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vaccine-induced CD8+ T cells control AIDS virus replication.
    Mudd PA; Martins MA; Ericsen AJ; Tully DC; Power KA; Bean AT; Piaskowski SM; Duan L; Seese A; Gladden AD; Weisgrau KL; Furlott JR; Kim YI; Veloso de Santana MG; Rakasz E; Capuano S; Wilson NA; Bonaldo MC; Galler R; Allison DB; Piatak M; Haase AT; Lifson JD; Allen TM; Watkins DI
    Nature; 2012 Nov; 491(7422):129-33. PubMed ID: 23023123
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improved protection of rhesus macaques against intrarectal simian immunodeficiency virus SIV(mac251) challenge by a replication-competent Ad5hr-SIVenv/rev and Ad5hr-SIVgag recombinant priming/gp120 boosting regimen.
    Zhao J; Pinczewski J; Gómez-Román VR; Venzon D; Kalyanaraman VS; Markham PD; Aldrich K; Moake M; Montefiori DC; Lou Y; Pavlakis GN; Robert-Guroff M
    J Virol; 2003 Aug; 77(15):8354-65. PubMed ID: 12857905
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multispecific vaccine-induced mucosal cytotoxic T lymphocytes reduce acute-phase viral replication but fail in long-term control of simian immunodeficiency virus SIVmac239.
    Vogel TU; Reynolds MR; Fuller DH; Vielhuber K; Shipley T; Fuller JT; Kunstman KJ; Sutter G; Marthas ML; Erfle V; Wolinsky SM; Wang C; Allison DB; Rud EW; Wilson N; Montefiori D; Altman JD; Watkins DI
    J Virol; 2003 Dec; 77(24):13348-60. PubMed ID: 14645590
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 72.